Joshua A. Lile, Ph.D.
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Joshua A. Lile, Ph.D. sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Joshua A. Lile, Ph.D.: 7 sponsored US clinical trials, none currently recruiting.
Joshua A. Lile, Ph.D. sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cannabis Use Disorders, with 1 trials.
Upper-quartile sponsor footprint
Joshua A. Lile, Ph.D. sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
The Impact of Cobenfy Maintenance on Cocaine's Effects
NCT07624227
Behavioral Effects of Drugs Inpatient 44 Neurobehavioral Mechanisms of Opioid Choice
NCT06312657
Neurobehavioral Mechanisms of Cocaine Choice
NCT04296006
Neurobehavioral Mechanisms of Choice in Opioid Use Disorder
NCT03958474
Behavioral Effects of Pregabalin and Cannabis
NCT01511640
Impact of Sustained Release d-Amphetamine on Choice Between Cocaine and a Non-Drug Reinforcer
NCT02383043
Impact of a Non-Drug Choice on Cocaine Reinforcement
NCT01906346
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
Therapeutic Areas
How the Joshua A. Lile, Ph.D. early-phase archive is shaped
7 indexed studies, none listed as recruiting (0% open); 5 completed (71%).
Phase mix: 0 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: Cannabis Use Disorders (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Joshua A. Lile, Ph.D.: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Joshua A. Lile, Ph.D. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Joshua A. Lile, Ph.D. page
7 registered trials is a research-attention snapshot, not an endorsement of Joshua A. Lile, Ph.D. or any single study.
- None of Joshua A. Lile, Ph.D.'s trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Cannabis Use Disorders is the condition Joshua A. Lile, Ph.D. studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cannabis Use Disorders trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Joshua A. Lile, Ph.D. pipeline card: 7 registered trials from official public datasets.Report a data error.